The Merit WRAPSODY Central Feasibility Study (WAVE Central)

Merit Medical Systems

Status

Withdrawn

Conditions

Venous Occlusion

Venous Stenosis

Treatments

Device: Merit WRAPSODY Endovascular Stent Graft

Study type

Interventional

Funder types

Industry

Identifiers

NCT04541576

CVO-P3-20-01-F

Details and patient eligibility

About

The purpose of the study is to demonstrate the safety and efficacy of the Merit WRAPSODY Endovascular Stent Graft for treatment of stenosis or occlusion within the dialysis access outflow circuit in the thoracic central veins

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subject provides written informed consent
Subject is male or female, with an age ≥ 18 years at date of enrollment.
Subject is willing to undergo all follow-up assessments.
Subject has a life expectancy ≥ 12 months.
Subject is undergoing chronic hemodialysis.
Subject has either a mature AVF or AVG in the arm.
Target lesion(s) involves a non-stented restenotic lesion.
Target lesion has ≥50% stenosis.
Target lesion(s) reference vessel diameter is between 5.0 mm and 14.0 mm

Exclusion criteria

Subject is unable or is unwilling to comply with the procedural requirements of the study protocol.
Subject has a comorbidity that in the investigator's opinion would limit life expectancy to less than 12 months.
Subject has a known or suspected infection of the hemodialysis access site, systemic infection and/or septicemia.
Subject has a stroke diagnosis within 3 months prior to enrollment.
Subject has a history of unstable angina or myocardial infarction within 60 days prior to enrollment.
Subject is pregnant, breastfeeding, or intending to become pregnant within the next year.
Target lesion is located within a stent / stent graft.